Insulet Corporation - Common Stock (NQ:PODD)

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

2 Cash-Producing Stocks with Impressive Fundamentals and 1 Facing Challenges

February 08, 2026

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

February 05, 2026

Insulet Corp (NASDAQ:PODD) Matches Key Growth Rules in Navellier's "Little Book" Strategy ↗

February 04, 2026

Via Chartmill

Insulet Corp (NASDAQ:PODD) Passes Key Growth Screen with Strong Momentum ↗

January 14, 2026

Via Chartmill

2 S&P 500 Stocks to Research Further and 1 Facing Challenges

February 01, 2026

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Topics Stocks

Exploring the top movers within the S&P500 index during today's session. ↗

January 23, 2026

Via Chartmill

Which S&P500 stocks are moving on Friday? ↗

January 23, 2026

Via Chartmill

1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Find Risky

January 20, 2026

Join us as we evaluate Insulet's potential in the diabetes management market. With a unique product offering and strong growth, could this stock be your next big investment?

Is Insulet (PODD) the Future of Diabetes Management? ↗

January 20, 2026

Via The Motley Fool

What's going on in today's session: S&P500 gap up and gap down stocks ↗

January 09, 2026

Via Chartmill

Precision Medicine and the Tubeless Revolution: An In-Depth Look at Insulet Corporation (PODD)

January 09, 2026

Today’s Date: January 9, 2026 Introduction In the rapidly evolving landscape of medical technology, few companies have managed to fundamentally reshape a multi-decade standard of care as successfully...

Via PredictStreet

Topics Economy Product Recall World Trade

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

January 09, 2026

Get insights into the top movers in the S&P500 index of Wednesday's pre-market session. ↗

Which S&P500 stocks are showing activity after the closing bell on Wednesday? ↗

January 07, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's after-hours session. ↗

January 07, 2026

Via Chartmill

January 07, 2026

Via Chartmill

3 Healthcare Stocks with Exciting Potential

January 06, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their...

Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

Topics Stocks

January 06, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

2 Mid-Cap Stocks to Own for Decades and 1 That Underwhelm

December 30, 2025

Insulet Corp (NASDAQ:PODD) Presents a Classic Growth at a Reasonable Price (GARP) Case ↗

Topics Artificial Intelligence

December 29, 2025

Insulet Corp (PODD) exemplifies Growth at a Reasonable Price (GARP) with strong earnings growth, solid financials, and a valuation justified by its sector and future potential.

Via Chartmill

Insulet Corp (NASDAQ:PODD) Passes Key Growth Stock Screen from "The Little Book That Makes You Rich" ↗

December 23, 2025

Insulet Corp (PODD) exemplifies a high-growth stock, meeting key criteria for accelerating earnings, sales, and cash flow with strong profitability.

Via Chartmill

Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

December 16, 2025

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

December 15, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.

Patient Monitoring Stocks Q3 In Review: Insulet (NASDAQ:PODD) Vs Peers

December 08, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Topics Artificial Intelligence

Friday's session: top gainers and losers in the S&P500 index ↗

December 05, 2025

Via Chartmill

These S&P500 stocks are moving in today's session ↗

December 05, 2025

Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

2 High-Flying Stocks with Impressive Fundamentals and 1 We Turn Down

December 04, 2025

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated...

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

Topics Energy

December 04, 2025

Insulet Corp. exemplifies a disciplined growth investing strategy, showcasing accelerating revenue, earnings, and cash flow that meet strict financial filters for stock selection.

Insulet Corp. (NASDAQ:PODD) Embodies a Proven Growth Investing Strategy ↗

December 02, 2025

Via Chartmill

2 Growth Stocks with Explosive Upside and 1 We Find Risky

December 01, 2025

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.